BackSEP Acquisition - Warrants (27/07/2026) Overview

SEP Acquisition - Warrants (27/07/2026) Total Current Liabilities

Track SEP Acquisition - Warrants (27/07/2026)'s total current liabilities ($2.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$2.29M
3441.47% YoYΔ $2.22M vs prior year quarter

Peer average

Loading

SEP Acquisition - Warrants (27/07/2026) Total Current Liabilities History

Loading

SEP Acquisition - Warrants (27/07/2026) vs. peers: Total Current Liabilities Comparison

Loading

SEP Acquisition - Warrants (27/07/2026) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SEP Acquisition - Warrants (27/07/2026) (MEACW) FAQ

As of the most recent data (September 2023), MEACW shows a total current liabilities of $2.3M. That compares with $65K in the prior-year period — up 3441.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MEACW's total current liabilities is now $2.3M (was $65K) — a 3441.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SEP Acquisition - Warrants (27/07/2026) is outperforming or lagging.

Tracking MEACW's total current liabilities over time shows whether SEP Acquisition - Warrants (27/07/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.3M That compares with $65K in the prior-year period — up 3441.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has SEP Acquisition - Warrants (27/07/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $2.3M) with ownership activity and broader fundamentals.